Resources 
    • About Us 

    • Home Report Store Artificial Intelligence in Drug Discovery Market
    Artificial Intelligence in Drug Discovery Market

    Artificial Intelligence in Drug Discovery Market by Offering (Software, Service), Application (Target Discovery, Lead Identification, Clinical Testing), Therapy Area (Oncology, Cardiology, Neurodegenerative), Deployment, End User—Global Forecast to 2030

    Report ID:MRHC - 104745 Pages: 200 Jun-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours

    The Artificial Intelligence in Drug Discovery Market is projected to reach $8.95 billion by 2030, at a CAGR of 27.2% from 2024 to 2030.

     Pharmaceutical companies face several challenges during drug development, including timelines, high investment in R&D, and regulatory challenges. The need for developing and manufacturing advanced therapies has increased, resulting in newer challenges such as the collection and analysis of large data, the need for qualified professionals, and data security. Artificial intelligence (AI) is the replication of human intelligence processes. The use of AI has been increasing in various sectors, especially in the pharmaceutical industry. AI is used in R&D, drug development, diagnosis, disease prevention, remote monitoring, and epidemic prediction in the pharmaceutical industry. The adoption of AI in pharmaceutical drug discovery has enabled better success rates, quicker & faster delivery processes, and access to new biology.

    The growth of the AI in drug discovery market is attributed to the rising focus on reducing the turnaround time in drug discovery, growing applications of AI in drug discovery, the rising incidence of chronic diseases, and the high risk of emerging infectious diseases. The rising adoption of machine learning (ML) in drug discovery, the emergence of local and regional start-ups in AI in drug discovery, and rising investments in R&D are creating opportunities for the growth of this market.

    The Rise in the Incidence of Chronic Diseases Propels the Need for Artificial Intelligence (AI) in Drug Discovery

    The incidence of chronic diseases, including chronic obstructive pulmonary disease (COPD), diabetes, coronary artery disease, hepatitis, arthritis, and cancer, is rising. According to the Centers for Disease Control and Prevention (CDC) data published in December 2022, six in ten adults in the U.S. have a chronic disease. Furthermore, according to the European Commission, in 2021, over 35.2% of the people in the European Union were reported to have chronic diseases.

    According to the International Diabetes Federation, in 2020, 502 million people worldwide were diagnosed with diabetes. By 2030, 23.4 million new cases of cancer are expected to develop annually. Among all cancer types, lung cancer is the most common form leading to mortality in Asia-Pacific. Apart from cancer, the prevalence of several additional diseases has also increased over the years. Thus, the high prevalence of chronic diseases is driving the development and manufacturing of advanced therapies, boosting the applications of AI in drug discovery.

    Artificial Intelligence in Drug Discovery Market

    Click here to: Get Free Sample Copy of this report

    The Rise in the Investments for Artificial Intelligence in Drug Discovery Creates Opportunity for this Market

    After significant advancements in AI, its applications in drug discovery are rising. This is indicated by the increasing investments and a rise in the number of collaborations between pharmaceutical industries and AI companies. According to Stanford University’s Institute for Human-Centered Artificial Intelligence’s (HAI) Artificial Intelligence Index, investments in AI in drug discovery reached USD 13.8 billion in 2020. In April 2021, Exscientia (U.K.), a clinical-stage pharma tech company using artificial intelligence (AI) to design patient-based drugs, completed USD 225 million Series D funding round to continue expanding its proprietary pipeline and end-to-end AI drug discovery capabilities.

    Key Findings in the Global Artificial Intelligence in Drug Discovery Market study:

    Based on offering, in 2024, the software segment is expected to account for the largest share of this market

    In 2024, the software segment is expected to account for the largest share of the AI in drug discovery market. AI in drug discovery software is used for faster, efficient, and cost-effective drug discovery and enhanced clinical trials. Thus, the growing interest of pharmaceutical companies in developing novel therapies has increased the adoption of AI in drug discovery software.

    Based on deployment mode, the cloud-based segment is projected to register the highest CAGR over the forecast period

    The cloud-based segment is projected to register the highest CAGR over the forecast period. The demand for cloud-based and web-based platforms is growing due to the benefits of cloud-based models in terms of security and flexibility, high-capacity data storage, quick accessibility, and cost-effectiveness.

    Based on application, in 2024, the lead compound identification segment is expected to account for the largest share of this market

    In 2024, the lead compound identification segment is expected to account for the largest share of the AI in drug discovery market. The large market share of this segment is attributed to the benefits and importance of lead compound identification in drug discovery. Lead compound identification is a crucial step in drug discovery which is likely to finalize the compounds in drug discovery to reach lead compound optimization and, ultimately, to the clinical candidate development phase. Additionally, the use of AI in lead compound identification helps minimize time and cost.

    Based on therapeutic area, in 2024, the oncology segment is expected to account for the largest share of this market

    In 2024, the oncology segment is expected to account for the largest share of the AI in drug discovery market. Most drug discovery companies focus on oncology for the drug discovery process. The high prevalence of cancer and the availability of funding for oncology research are the factors contributing to the large market share of this segment. Furthermore, a large number of collaborations between pharmaceutical companies and AI companies is also contributing to this segment’s large market share.

    Based on end user, in 2024, the pharmaceutical & biotechnological companies segment is expected to account for the largest share of this market

    Pharmaceutical and biopharmaceutical companies are employing AI to find new drugs. These companies focus on reducing operating costs associated with the production of drugs and accelerating the introduction of new treatments to the market. Pharmaceutical companies are under pressure to find new drugs due to the rising burden of chronic and infectious diseases. Thus, pharmaceutical and biopharmaceutical companies are integrating AI into drug research to speed up drug discovery while reducing costs and time to market.

    Asia-Pacific: Fastest growing regional market

    The emerging infrastructure for AI and pharmaceutical research in countries such as China, India, Singapore, and South Korea, rising funding for cancer research, and growing investments in AI are driving the growth of the AI in drug discovery market in Asia-Paicifc. Furthermore, the growing number of AI-based drug discovery startups is also boosting the growth of this market.

    Key Players

    The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by key market players over the past few years. The key players profiled in the global AI in drug discovery market report are Microsoft Corporation (U.S.), Exscientia plc (U.K.), NVIDIA Corporation (U.S.), Schrödinger, LLC (U.S.), Atomwise, Inc. (U.S.), BenevolentAI Limited (U.K.), Deep Genomics Incorporated (Canada), InSilico Medicine (U.S.), Cloud Pharmaceuticals, Inc. (U.S.), and Standigm Inc. (South Korea).

    Scope of the Report

    Artificial Intelligence in Drug Discovery Market, by Offering

    • Software
    • Services

    Artificial Intelligence in Drug Discovery Market, by Deployment Mode

    • On-premises
    • Cloud & Web-Based Mode

    Artificial Intelligence in Drug Discovery Market, by Application

    • Target Discovery & Validation
    • Lead Compound Identification
    • De Novo Design and Drug Optimization
    • Preclinical & Clinical Testing

    Artificial Intelligence in Drug Discovery Market, by Therapeutic Area

    • Oncology
    • Neurodegenerative Diseases
    • Cardiovascular Diseases
    • Metabolic Diseases
    • Other Therapeutic Areas
      (Note: Other therapeutic areas include infectious diseases and rare diseases.)

    Artificial Intelligence in Drug Discovery Market, by End User

    • Pharmaceutical & Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Academic & Research Institutes

    Artificial Intelligence in Drug Discovery Market, by Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • Asia-Pacific
      • China
      • Japan
      • India
      • Rest of APAC (RoAPAC)
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America (RoLA)
    • Middle East & Africa

    Key questions answered in the report:

    This study offers a detailed assessment of the AI in drug discovery market and includes the market size & forecast for various segmentations such as offering, deployment mode, therapeutic area, application, and end user. The AI in drug discovery market study also involves the value analysis of various segments of the AI in drug discovery market at regional and country levels.

    The global AI in drug discovery market is projected to reach $8.95 billion by 2030, at a CAGR of 27.2% during the forecast period.

    Based on offering, in 2024, the software segment is expected to account for the largest share. Recurring revenue from the companies owing to the subscription-based or licensing models offered by the software companies are the factors attributed to the large market share of this segment.

    Based on deployment mode, the cloud & web-based segment is projected to register the highest CAGR over the forecast period. Growing preference for cloud-based and web-based models owing to their advantages contribute to the growth of this market.

    The growth of the AI in drug discovery market is attributed to the rising focus on reducing the turnaround time in drug discovery, growing applications of AI in drug discovery, the rising incidence of chronic diseases, and the high risk of emerging infectious diseases. The rising adoption of machine learning (ML) in drug discovery, the emergence of local and regional start-ups in AI in drug discovery, and increasing investments in R&D are also creating opportunities for market growth.

    The key players profiled in the global AI in drug discovery market are Microsoft Corporation (U.S.), Exscientia plc (U.K.), NVIDIA Corporation (U.S.), Schrödinger, LLC (U.S.), Atomwise, Inc. (U.S.), BenevolentAI Limited. (U.K.), Deep Genomics Incorporated (Canada), InSilico Medicine (U.S.), Cloud Pharmaceuticals, Inc. (U.S.), and Standigm Inc. (South Korea).

    Emerging economies like China and India are projected to offer significant growth opportunities to the market players due to the availability of infrastructure for drug discovery research, leading to the growing adoption of AI in drug discovery in these countries.

    Enquire
    Check Discount
    Related Tag: Drug Discovery Artificial Intelligence in Drug Discovery AI in Drug Development AI in clinical development
    Artificial Intelligence
    Healthcare

    1.    Introduction 
           1.1.    Market Definition 
           1.2.    Market Ecosystem 
           1.3.    Currency 
           1.4.    Key Stakeholders 

    2.    Research Methodology 
           2.1.    Research Process 
           2.2.    Data Collection & Validation 
                     2.2.1.    Secondary Research 
                     2.2.2.    Primary Research 
           2.3.    Market Assessment 
                     2.3.1.    Market Size Estimation 
                                  2.3.1.1.    Bottom-up Approach 
                                  2.3.1.2.    Top-down Approach 
                                  2.3.1.3.    Growth Forecast 
                     2.3.2.    Market Share Analysis 
           2.4.    Assumptions for the Study 
           2.5.    Limitations for the Study 

    3.    Executive Summary 

    4.    Market Insights 
           4.1.    Introduction 
           4.2.    Drivers 
                     4.2.1.    Rising Focus on Reducing Turnaround Time in Drug Discovery 
                     4.2.2.    Growing Applications of AI in Drug Discovery
                     4.2.3.    Rising Incidences of Chronic Diseases
                     4.2.4.    Rising Collaborations and Partnerships to Accelerate the Drug Discovery and Development
           4.3.    Restraints 
                     4.3.1.    Limited Availability of Resources for Integration of AI in Drug Discovery 
           4.4.    Opportunity 
                     4.4.1.    Emerging Economies 
                     4.4.2.    Rise in the Investments for R&D
           4.5.    Challenges 
                     4.5.1.    Limited Availability of Data Setss
           4.6.    Impact of COVID-19 on the AI in Drug Discovery Market

    5.    Global AI in Drug Discovery Market, by Offering 
           5.1.    Introduction 
           5.2.    Software 
           5.3.    Services 

    6.    Global AI in Drug Discovery Market, by Deployment Mode 
           6.1.    Introduction 
           6.2.    Cloud & Web-based Mode 
           6.3.    On-premises Mode

    7.    Global AI in Drug Discovery Market, by Application 
           7.1.    Introduction 
           7.2.    Target Discovery & Validation 
           7.3.    Lead Compound Identification
           7.4.    De Novo Design & Drug Optimization
           7.5.    Preclinical & Clinical Testing

    8.    Global AI in Drug Discovery Market, by Therapeutic Area 
           8.1.    Introduction 
           8.2.    Oncology
           8.3.    Neurodegenerative Diseases
           8.4.    Cardiovascular Diseases
           8.5.    Metabolic Diseases
           8.6.    Other Therapeutic Areas

    9.    Global AI in Drug Discovery Market, by End User 
           9.1.    Introduction 
           9.2.    Pharmaceutical & Biotechnology Companies 
           9.3.    Contract Research Organizations (CROs)
           9.4.    Academic & Research Institutes

    10.    AI in Drug Discovery Market, by Geography 
             10.1.    Introduction     
             10.2.    North America 
                         10.2.1.    U. S. 
                         10.2.2.    Canada 
             10.3.    Europe 
                         10.3.1.    Germany 
                         10.3.2.    France 
                         10.3.3.    U.K. 
                         10.3.4.    Italy 
                         10.3.5.    Spain
                         10.3.6.    Rest of Europe 
             10.4.    Asia-Pacific 
                         10.4.1.    China 
                         10.4.2.    Japan 
                         10.4.3.    India 
                         10.4.4.    Rest of Asia-Pacific 
             10.5.    Latin America 
                         10.5.1.    Brazil 
                         10.5.2.    Mexico 
                         10.5.3.    Rest of Latin America 
             10.6.    Middle East & Africa 

    11.    Competitive Landscape 
             11.1.    Introduction 
             11.2.    Key Growth Strategies 
             11.3.    Competitive Benchmarking 
             11.4.    Market Share Analysis (2022) 

    12.    Company Profiles (Business Overview, Financial Overview, Solutions Portfolio, and Strategic Developments)
             12.1.    Microsoft Corporation 
             12.2.    Exscientia plc 
             12.3.    NVIDIA Corporation
             12.4.    Schrödinger, LLC 
             12.5.    Atomwise, Inc. 
             12.6.    BenevolentAI Limited
             12.7.    Deep Genomics Incorporated 
             12.8.    InSilico Medicine 
             12.9.    Cloud Pharmaceuticals, Inc. 
             12.10.    Standigm Inc. 

    13.    Appendix 
             13.1.    Questionnaire 
             13.2.    Available Customization 
     

    List of Tables
    Table 1    Global AI in Drug Discovery Market Drivers: Impact Analysis (2024–2030) 
    Table 2    Global AI in Drug Discovery Market Restraints: Impact Analysis (2024–2030) 
    Table 3    Global AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 4    Global AI in Drug Discovery Software Market Size, by Country/Region, 2021–2030 (USD Million) 
    Table 5    Global AI in Drug Discovery Services Market Size, by Country/Region, 2021–2030 (USD Million) 
    Table 6    Global AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 7    Global AI in Drug Discovery Market Size for Cloud & Web-Based Mode, by Country/Region, 2021–2030 (USD Million) 
    Table 8    Global AI in Drug Discovery Market Size for On-Premises Mode, by Country/Region, 2021–2030 (USD Million) 
    Table 9    Global AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 10    Global AI in Drug Discovery Market Size for Target Discovery & validation, by Country/Region, 2021–2030 (USD Million) 
    Table 11    Global AI in Drug Discovery Market Size for Lead Compound Identification, by Country/Region, 2021–2030 (USD Million) 
    Table 12    Global AI in Drug Discovery Market Size for De Novo Design and Drug Optimization, by Country/Region, 2021–2030 (USD Million) 
    Table 13    Global AI in Drug Discovery Market Size for Preclinical & Clinical Testing, by Country/Region, 2021–2030 (USD Million) 
    Table 14    Global AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 15    Global AI in Drug Discovery Market Size for Oncology, by Country/Region, 2021–2030 (USD Million) 
    Table 16    Global AI in Drug Discovery Market Size for Neurodegenerative Diseases, by Country/Region, 2021–2030 (USD Million) 
    Table 17    Global AI in Drug Discovery Market Size for Cardiovascular Diseases, by Country/Region, 2021–2030 (USD Million) 
    Table 18    Global AI in Drug Discovery Market Size for Metabolic Diseases, by Country/Region, 2021–2030 (USD Million) 
    Table 19    Global AI in Drug Discovery Market Size for Other Therapeutic Areas, by Country/Region, 2021–2030 (USD Million) 
    Table 20    Global AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 21    Global AI in Drug Discovery Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021–2030 (USD Million) 
    Table 22    Global AI in Drug Discovery Market Size for Contract Research Organizations (CROs), by Country/Region, 2021–2030 (USD Million) 
    Table 23    Global AI in Drug Discovery Market Size for Academic & Research Institutes, by Country/Region, 2021–2030 (USD Million)
    Table 24    Global AI in Drug Discovery Market Size, by Country/Region, 2021–2030 (USD Million) 
    Table 25    North America: AI in Drug Discovery Market Size, by Country, 2021–2030 (USD Million) 
    Table 26    North America: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 27    North America: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 28    North America: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 29    North America: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 30    North America: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 31    U.S.: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 32    U.S.: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 33    U.S.: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 34    U.S.: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 35    U.S.: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 36    Canada.: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 37    Canada: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 38    Canada: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 39    Canada: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 40    Canada.: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 41    Europe: AI in Drug Discovery Market Size, by Country/Region, 2024–2030 (USD Million)) 
    Table 42    Europe: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 43    Europe: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 44    Europe: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 45    Europe: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 46    Europe: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 47    Germany: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 48    Germany: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 49    Germany: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 50    Germany: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 51    Germany: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 52    France: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 53    France: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 54    France: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 55    France: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 56    France: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 57    U.K.: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 58    U.K.: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 59    U.K.: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 60    U.K.: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 61    U.K.: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 62    Italy: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 63    Italy: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 64    Italy: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 65    Italy: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 66    Italy: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 67    Spain: AI in Drug Discovery Market Size, by Offerings, 2021–2030 (USD Million) 
    Table 68    Spain: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 69    Spain: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 70    Spain: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 71    Spain: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 72    Rest of Europe: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 73    Rest of Europe: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 74    Rest of Europe: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 75    Rest of Europe: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 76    Rest of Europe: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 77    Asia-Pacific: AI in Drug Discovery Market Size, by Country/Region, 2021–2030 (USD Million) 
    Table 78    Asia-Pacific: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 79    Asia-Pacific: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 80    Asia-Pacific: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 81    Asia-Pacific: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 82    Asia-Pacific: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 83    China: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 84    China: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 85    China: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 86    China: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 87    China: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 88    Japan: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 89    Japan: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 90    Japan: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 91    Japan: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 92    Japan: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 93    India: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 94    India: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 95    India: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 96    India: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 97    India: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 98    Rest of Asia Pacific: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 99    Rest of Asia Pacific: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 100    Rest of Asia Pacific: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 101    Rest of Asia Pacific: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 102    Rest of Asia Pacific: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 103    Latin America: AI in Drug Discovery Market Size, by Country/Region, 2020-2029 (USD Million) 
    Table 104    Latin America: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 105    Latin America: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 106    Latin America: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 107    Latin America: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 108    Latin America: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 109    Brazil: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 110    Brazil: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 111    Brazil: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 112    Brazil: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 113    Brazil: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 114    Mexico: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 115    Mexico: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 116    Mexico: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 117    Mexico: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 118    Mexico: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 119    Rest of Latin America: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 120    Rest of Latin America: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 121    Rest of Latin America: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 122    Rest of Latin America: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 123    Rest of Latin America: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 124    Middle East & Africa: AI in Drug Discovery Market Size, by Offering, 2021–2030 (USD Million) 
    Table 125    Middle East & Africa: AI in Drug Discovery Market Size, by Deployment Mode, 2021–2030 (USD Million) 
    Table 126    Middle East & Africa: AI in Drug Discovery Market Size, by Therapeutic Area, 2021–2030 (USD Million) 
    Table 127    Middle East & Africa: AI in Drug Discovery Market Size, by Application, 2021–2030 (USD Million) 
    Table 128    Middle East & Africa: AI in Drug Discovery Market Size, by End User, 2021–2030 (USD Million) 
    Table 129    Recent Developments, by Company, 2020–2022

    List of Figures
    Figure 1    Research Process 
    Figure 2    Key Secondary Sources 
    Figure 3    Primary Research Techniques 
    Figure 4    Key Executives Interviewed 
    Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side) 
    Figure 6    Market Size Estimation 
    Figure 7    Global AI in Drug Discovery Market Size, by Offering, 2024–2030 (USD Million) 
    Figure 8    Global AI in Drug Discovery Market Size, by Deployment Mode, 2024–2030 (USD Million) 
    Figure 9    Global AI in Drug Discovery Market Size, by Therapeutic Area, 2024–2030 (USD Million) 
    Figure 10    Global AI in Drug Discovery Market Size, by Application, 2024–2030 (USD Million) 
    Figure 11    Global AI in Drug Discovery Market Size, by End User, 2024–2030 (USD Million) 
    Figure 12    Global AI in Drug Discovery Market, by Geography 
    Figure 13    Market Dynamics: AI in Drug Discovery Market 
    Figure 14    Global AI in Drug Discovery Market Size, by Offering, 2024–2030 (USD Million)
    Figure 15    Global AI in Drug Discovery Market Size, by Deployment Mode, 2024–2030 (USD Million)
    Figure 16    Global AI in Drug Discovery Market Size, by Therapeutic Area, 2024–2030 (USD Million) 
    Figure 17    Global AI in Drug Discovery Market Size, by Application, 2024–2030 (USD Million)
    Figure 18    Global AI in Drug Discovery Market Size, by End User, 2024–2030 (USD Million) 
    Figure 19    Global AI in Drug Discovery Market Size, by Geography, 2024–2030 (USD Million) 
    Figure 20    North America: AI in Drug Discovery Market Snapshot 
    Figure 21    Europe: AI in Drug Discovery Market Size Snapshot 
    Figure 22    Asia-Pacific: AI in Drug Discovery Market Size Snapshot 
    Figure 23    Latin America: AI in Drug Discovery Market Size Snapshot 
    Figure 24    Key Growth Strategies Adopted by Leading Players, 2020–2022
    Figure 25    AI in Drug Discovery Market: Competitive Benchmarking by Offering
    Figure 26    AI in Drug Discovery Market: Competitive Benchmarking by Geography
    Figure 27    Market Share Analysis: AI in Drug Discovery Market, 2022
    Figure 28    Microsoft Corporation: Financial Overview (2021) 
    Figure 29    Exscientia plc: Financial Overview (2021)
    Figure 30    NVIDIA Corporation: Financial Overview (2021) 
    Figure 31    Schrödinger, LLC: Financial Overview (2021)
    Figure 32    BenevolentAI Limited: Financial Overview (2021)
     

    Enquire
    Check Discount
    Author Name:

    Madhura Pawar, Pranjali Takale

    Related Tag: Drug Discovery Artificial Intelligence in Drug Discovery AI in Drug Development AI in clinical development
    Artificial Intelligence
    Healthcare
      This website is secure and we do not share your personal information with any third party. privacy policy

      Proudly Partnering With Enterprises Around the Globe

      Accenture Amazon BCG-Corporate BioRad Boehringer-Ingelheim Deloitte Fujifilm Intel PEPSICO Samsung Olympus McKinsey LG-Chem Rosetta-Stone tata-consultancy-services SK Kao IQVIA Vemag Canada Genscript Grupo-Vilaseca HEC Highland-Metals-Inc
      Related Tag: Drug Discovery Artificial Intelligence in Drug Discovery AI in Drug Development AI in clinical development
      Request Sample
      Customize My Report
      Quick Contact
      Chat on Whatsapp
      Linkdin
      Whatsapp
      Feed
      Related Reports
      Artificial Intelligence in Genomics Market - Global Opportunity Analysis And Industry Forecast (2022-2029)

         Published Date: Dec-2022

      Artificial Intelligence in Medical Diagnostics Market - Global Opportunity Analysis And Industry Forecast (2022-2029)

         Published Date: Oct-2022

      NGS Automation Market - Global Opportunity Analysis and Industry Forecast (2022-2029)

         Published Date: Jun-2022

      Digital Pathology Market - Global Opportunity Analysis and Industry Forecast (2024-2030)

         Published Date: Jun-2024

      Label-free Detection Market - Global Opportunity Analysis and Industry Forecast (2024-2031)

         Published Date: Sep-2024

      Table Of Content
      Download Free Sample Report
      Meticulous Research
      US
      +1 646-781-8004
      Meticulous Research
      Europe
      +44-203-868-8738
      Meticulous Research
      APAC
      +91-744-778-0008